相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis
Marta Tonon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Local and Regional Therapies for Hepatocellular Carcinoma
Roman Kloeckner et al.
HEPATOLOGY (2021)
Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma Is There a Limit?
Allison Kwong et al.
CLINICS IN LIVER DISEASE (2021)
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis
Jose Ferrusquia-Acosta et al.
JOURNAL OF HEPATOLOGY (2021)
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
Maria Reig et al.
LIVER INTERNATIONAL (2021)
Systemic treatment of hepatocellular carcinoma: An EASL position paper
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2021)
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
Amit G. Singal et al.
GASTROENTEROLOGY (2021)
Methods of Public Health Research - Strengthening Causal Inference from Observational Data
Miguel A. Hernan
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Endpoints in clinical trials for liver cancer and their value in evidence-based clinical decision making: An unresolved Gordian knot
Jordi Bruix
JOURNAL OF HEPATOLOGY (2021)
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
Riad Salem et al.
HEPATOLOGY (2021)
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
W. Ray Kim et al.
GASTROENTEROLOGY (2021)
Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival
Joana Ferrer-Fabrega et al.
JOURNAL OF HEPATOLOGY (2021)
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes
Mihir D. Shanker et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2021)
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Won Jin Ho et al.
NATURE CANCER (2021)
Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study
R. Troisi et al.
BRITISH JOURNAL OF SURGERY (2021)
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis
Giammauro Berardi et al.
JOURNAL OF HEPATOLOGY (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT
Manuel de la Torre-Alaez et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Informative censoring - a neglected cause of bias in oncology trials
Arnoud J. Templeton et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2020)
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
Neil Mehta et al.
TRANSPLANTATION (2020)
Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma A PRISMA-compliant systematic review and meta-analysis
Jie Han et al.
MEDICINE (2020)
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
John D. Gordan et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Role of External Beam Radiotherapy in Hepatocellular Carcinoma
Chien Peter Chen
CLINICS IN LIVER DISEASE (2020)
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol et al.
GUT (2019)
Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients
Jan Witowski et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2019)
A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
Namiki Izumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery
Enric Reverter et al.
JOURNAL OF HEPATOLOGY (2019)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Jens Ricke et al.
JOURNAL OF HEPATOLOGY (2019)
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Jean-Luc Raoul et al.
CANCER TREATMENT REVIEWS (2019)
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients
Adam Doyle et al.
JOURNAL OF HEPATOLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study
Victor Molina et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Clinical states of cirrhosis and competing risks
Gennaro D'Amico et al.
JOURNAL OF HEPATOLOGY (2018)
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
Richard S. Finn et al.
JOURNAL OF HEPATOLOGY (2018)
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
Jean-Charles Nault et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
Lorenza Rimassa et al.
LANCET ONCOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Vogel et al.
ANNALS OF ONCOLOGY (2018)
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
Anthony W. H. Chan et al.
JOURNAL OF HEPATOLOGY (2018)
Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial
Naik Vietti Violi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
Jie Yu et al.
GUT (2017)
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials
Antonio Facciorusso et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2017)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
David J. Pinato et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma
K. K. C. Ng et al.
BRITISH JOURNAL OF SURGERY (2017)
Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing
Ruben Ciria et al.
ANNALS OF SURGERY (2016)
Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma
C. Sposito et al.
BRITISH JOURNAL OF SURGERY (2016)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
Prospective Validation of Ab Initio Liver Transplantation in Hepatocellular Carcinoma Upon Detection of Risk Factors for Recurrence After Resection
Joana Ferrer-Fabrega et al.
HEPATOLOGY (2016)
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
Karen T. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Primary Outcome Is Positive - Is That Good Enough?
Stuart J. Pocock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
Davide Citterio et al.
JAMA SURGERY (2016)
When to Perform Hepatic Resection for Intermediate-Stage Hepatocellular Carcinoma
Alessandro Cucchetti et al.
HEPATOLOGY (2015)
Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
Francis Y. Yao et al.
HEPATOLOGY (2015)
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
Christian Toso et al.
HEPATOLOGY (2015)
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
Massimo Iavarone et al.
HEPATOLOGY (2015)
Portal Hypertension and the Outcome of Surgery for Hepatocellular Carcinoma in Compensated Cirrhosis: A Systematic Review and Meta-analysis
Annalisa Berzigotti et al.
HEPATOLOGY (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease
Zenichi Morise et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study
Alessandro Vitale et al.
JOURNAL OF HEPATOLOGY (2015)
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
Roberto de Franchis
JOURNAL OF HEPATOLOGY (2015)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
Alpha-Fetoprotein Level > 1000 ng/mL as an Exclusion Criterion for Liver Transplantation in Patients With Hepatocellular Carcinoma Meeting the Milan Criteria
Bilal Hameed et al.
LIVER TRANSPLANTATION (2014)
Treatment of intermediate-stage hepatocellular carcinoma
Alejandro Fomer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
T. Meyer et al.
BRITISH JOURNAL OF CANCER (2013)
Postprogression Survival of Patients With Advanced Hepatocellular Carcinoma: Rationale for Second-Line Trial Design
Maria Reig et al.
HEPATOLOGY (2013)
Yttrium-90 Radioembolization for Intermediate-Advanced Hepatocellular Carcinoma: A Phase 2 Study
Vincenzo Mazzaferro et al.
HEPATOLOGY (2013)
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
Alessandro Cucchetti et al.
JOURNAL OF HEPATOLOGY (2013)
Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey
Maurizio Pompili et al.
JOURNAL OF HEPATOLOGY (2013)
Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection
Michael Vouche et al.
JOURNAL OF HEPATOLOGY (2013)
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
Shuichiro Shiina et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention-to-treat analysis
David Fuks et al.
HEPATOLOGY (2012)
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
Kai Feng et al.
JOURNAL OF HEPATOLOGY (2012)
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
Marta Burrel et al.
JOURNAL OF HEPATOLOGY (2012)
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study
Giuseppe Cabibbo et al.
WORLD JOURNAL OF HEPATOLOGY (2012)
Clinical Decision Making and Research in Hepatocellular Carcinoma: Pivotal Role of Imaging Techniques
Jordi Bruix et al.
HEPATOLOGY (2011)
Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation
Bruno Sangro et al.
HEPATOLOGY (2011)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Multifaceted Perspective of the Waiting List for Liver Transplantation: The Value of Pharmacokinetic Models
Miquel Navasa et al.
HEPATOLOGY (2010)
Now There Are Many (Stages) Where Before There Was One: In Search of a Pathophysiological Classification of Cirrhosis
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2010)
Hepatic Resection Versus Radiofrequency Ablation for Very Early Stage Hepatocellular Carcinoma: A Markov Model Analysis
Yun Ku Cho et al.
HEPATOLOGY (2010)
Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival
Philip Hilgard et al.
HEPATOLOGY (2010)
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis
Giacomo Germani et al.
JOURNAL OF HEPATOLOGY (2010)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Radiofrequency Ablation of Hepatocellular Carcinoma: Long-term Results and Prognostic Factors in 235 Western Patients with Cirrhosis
Gisele N'Kontchou et al.
HEPATOLOGY (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
J. Ignacio Herrero et al.
LIVER TRANSPLANTATION (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hyponatremia and mortality among patients on the liver-transplant waiting list
W. Ray Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Chemoembolization of hepatocellular carcinoma with drug eluting beads:: Efficacy and doxorubicin pharmacokinetics
Maria Varela et al.
JOURNAL OF HEPATOLOGY (2007)
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients
Kenichi Takayasu et al.
GASTROENTEROLOGY (2006)
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
MS Chen et al.
ANNALS OF SURGERY (2006)
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
S Shiina et al.
GASTROENTEROLOGY (2005)
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma:: An indication for salvage liver transplantation
M Sala et al.
LIVER TRANSPLANTATION (2004)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
A model to predict survival in patients with end-stage liver disease
PS Kamath et al.
HEPATOLOGY (2001)
分享论文
